The influence of concomitant antidepressant medication on safety, tolerability and clinical effectiveness of electroconvulsive therapy

World Journal of Biological Psychiatry

Volumn 7, Issue 2, 2006, Pages 82-90

  Baghai, Thomas C ^a   Marcuse, Alain ^a   Brosch, Melanie ^a   Schüle, Cornelius ^a   Eser, Daniela ^a   Nothdurfter, Caroline ^a   Steng, Yvonne ^a   Noack, Ines ^a   Pietschmann, Katrin ^a   Möller, Hans Jürgen ^a   Rupprecht, Rainer ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Antidepressant therapy; Concomitant medication; Electroconvulsive therapy; Major depression

Indexed keywords

ETOMIDATE; METHOHEXITAL; MIANSERIN; MIRTAZAPINE; MOCLOBEMIDE; NEUROLEPTIC AGENT; PROPOFOL; REBOXETINE; SEROTONIN UPTAKE INHIBITOR; TETRACYCLIC ANTIDEPRESSANT AGENT; THIOPENTAL; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; COGNITIVE DEFECT; CONTROLLED STUDY; DISEASE DURATION; DRUG EFFICACY; ELECTROCONVULSIVE THERAPY; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MONOTHERAPY; NEUROPHYSIOLOGY; OUTCOME ASSESSMENT; PSYCHOPHARMACOTHERAPY; RETROSPECTIVE STUDY; SAFETY; SEIZURE;

ADULT; AGED; ANESTHESIA; ANTIDEPRESSIVE AGENTS; COMBINED MODALITY THERAPY; DEPRESSIVE DISORDER; DRUG TOLERANCE; ELECTROCONVULSIVE THERAPY; FEMALE; HUMANS; MALE; MIDDLE AGED; PSYCHOTROPIC DRUGS; RETROSPECTIVE STUDIES; SAFETY; SEIZURES;

EID: 33646709182     PISSN: 15622975     EISSN: 18141412     Source Type: Journal    
DOI: 10.1080/15622970500213871     Document Type: Article

References (42)

1. Abrams, R. (1972) Recent clinical studies of ECT Semin Psychiatry, 4, pp. 3-12.
2. Abrams, R. (2002) Stimulus titration and ECT dosing J. ECT., 18, pp. 3-9.
3. Abrams, R and Swartz, CM and Vedak, C. (1991) Antidepressant effects of high-dose right unilateral electroconvulsive therapy Arch Gen Psychiatry, 48, pp. 746-748.
4. Agelink, MM and Zeit, T and Klieser, E. (1998) Prolonged bradycardia complicates antidepressive treatment with venlafaxine and ECT Br J Psychiatry, 173, pp. 441.
5. Baghai TC, Moller H-J, Rupprecht R. 2006. Recent progress in pharmacological and non-pharmacological treatment options of major depression. Curr Pharm Design 12:503-515. 503-515
6. Bernardo, M and Navarro, V and Salva, J and Arrufat, FJ and Baeza, I. (2000) Seizure activity and safety in combined treatment with venlafaxine and ECT: A pilot study J ECT, 16, pp. 38-42.
7. Coffey, CE and Lucke, J and Weiner, RD and Krystal, AD and Aque, M. (1995) Seizure threshold in electroconvulsive therapy: I. Initial seizure threshold Biol. Psychiatry, 37, pp. 713-720.
8. Conway, CR and Nelson, LA. (2001) The combined use of bupropion, lithium, and venlafaxine during ECT: A case of prolonged seizure activity J ECT, 17, pp. 216-218.
9. Curran, S. (1995) Effect of paroxetine on seizure length during electroconvulsive therapy Acta Psychiatr Scand, 92, pp. 239-240.
10. D'Elia, G. (1970) Unilateral electroconvulsive therapy Acta Psychiatr Scand, Suppl 215, pp. 1-98.
11. D'Elia, G and Raotma, H. (1975) Is unilateral ECT less effective than bilateral ECT? Br J Psychiatry, 126, pp. 83-89.
12. ECT Review Group. (2003) Efficacy and safety of electroconvulsive therapy in depressive disorders: A systematic review and meta-analysis Lancet, 361, pp. 799-808.
13. Folkerts, HW and Michael, N and Tolle, R and Schonauer, K and Mucke, S and Schulze-Monking, H. (1997) Electroconvulsive therapy vs. paroxetine in treatment-resistant depression - a randomized study Acta Psychiatr Scand, 96, pp. 334-342.
14. Frey, R and Heiden, A and Scharfetter, J and Schreinzer, D and Blasbichler, T and Tauscher, J and Felleiter, P and Kasper, S. (2001) Inverse relation between stimulus intensity and seizure duration: Implications for ECT procedure J ECT, 17, pp. 102-108.
15. Gonzalez-Pinto, A and Gutierrez, M and Gonzalez, N and Elizagarate, E and Perez De Heredia, JL and Mico, JA. (2002) Efficacy and safety of venlafaxine-ECT combination in treatment-resistant depression J Neuropsychiatry Clin Neurosci, 14, pp. 206-209.
16. Greenblatt M, Grosser GH, Wechsler HA. 1964. Differential response of hospitalized depressed patients in somatic therapy. Am J Psychiatry 935-943.
17. Gutierrez-Esteinou, R and Pope, HG, Jr. (1989) Does fluoxetine prolong electrically induced seizures? Convuls Ther, 5, pp. 344-348.
18. Hirschfeld, RM. (1999) Efficacy of SSRIs and newer antidepressants in severe depression: Comparison with TCAs J Clin Psychiatry, 60, pp. 326-335.
19. ICD-10 Task Force. (1987) Report of the ICD-10 Task Force. American Medical Record Association J Am Med Rec Assoc, 58, pp. 51-56.
20. Janicak, PG and Davis, JM and Gibbons, RD and Ericksen, S and Chang, S and Gallagher, P. (1985) Efficacy of ECT: A meta-analysis Am J Psychiatry, 142, pp. 297-302.
21. Jha, A and Tomar, R. (2002) Interaction between ECT and venlafaxine Int J Geriatr Psychiatry, 17, pp. 979-980.
22. Lauritzen, L and Odgaard, K and Clemmesen, L and Lunde, M and Ohrstrom, J and Black, C and Bech, P. (1996) Relapse prevention by means of paroxetine in ECT-treated patients with major depression: A comparison with imipramine and placebo in medium-term continuation therapy Acta Psychiatr Scand, 94, pp. 241-251.
23. Mayur, PM and Gangadhar, BN and Subbakrishna, DK and Janakiramaiah, N. (2000) Discontinuation of antidepressant drugs during electroconvulsive therapy: A controlled study J Affect Disord, 58, pp. 37-41.
24. McCall, WV and Reboussin, DM and Weiner, RD and Sackeim, HA. (2000) Titrated moderately suprathreshold vs fixed high-dose right unilateral electroconvulsive therapy: Acute antidepressant and cognitive effects Arch Gen Psychiatry, 57, pp. 438-444.
25. National Institute of Mental Health. 1976. 028 CGI. Clinical global impressions. In:GUyW, BonatoRR, editors. Manual for the EDCEU Assessment Battery, 2. Rev. Chevy Chase, MD: National Institute of Mental Health. pp 12-1-12-6.
26. Nelson, JP and Benjamin, L. (1989) Efficacy and safety of combined ect and tricyclic antidepressant drugs in the treatment of depressed geriatric patients Convuls Ther, 5, pp. 321-329.
27. Nobler, MS and Sackeim, HA and Solomou, M and Luber, B and Devanand, DP and Prudic, J. (1993) EEG manifestations during ECT: Effects of electrode placement and stimulus intensity. Biol Psychiatry, 34, pp. 321-330.
28. Parker, G and Mitchell, P and Wilhelm, K and Menkes, D and Snowdon, J and Schweitzer, I and Grounds, D and Skerritt, P and Roy, K and Hadzi-Pavlovic, D. (1999) Are the newer antidepressant drugs as effective as established physical treatments? Results from an Australasian clinical panel review Aust NZ J Psychiatry, 33, pp. 874-881.
29. Perera, TD and Luber, B and Nobler, MS and Prudic, J and Anderson, C and Sackeim, HA. (2004) Seizure expression during electroconvulsive therapy: Relationships with clinical outcome and cognitive side effects Neuropsychopharmacology, 29, pp. 813-825.
30. Prudic, J and Sackeim, HA and Devanand, DP. (1990) Medication resistance and clinical response to electroconvulsive therapy Psychiatry Res, 31, pp. 287-296.
31. Prudic, J and Haskett, RF and Mulsant, B and Malone, KM and Pettinati, HM and Stephens, S and Greenberg, R and Rifas, SL and Sackeim, HA. (1996) Resistance to antidepressant medications and short-term clinical response to ECT Am J Psychiatry, 153, pp. 985-992.
32. Sackeim, HA and Decina, P and Kanzler, M and Kerr, B and Malitz, S. (1987) Effects of electrode placement on the efficacy of titrated, low-dose ECT Am J Psychiatry, 144, pp. 1449-1455.
33. Sackeim, HA and Prudic, J and Devanand, DP and Kiersky, JE and Fitzsimons, L and Moody, BJ and McElhiney, MC and Coleman, EA and Settembrino, JM. (1993) Effects of stimulus intensity and electrode placement on the efficacy and cognitive effects of electroconvulsive therapy New Engl J Med, 328, pp. 839-846.
34. Sackeim, HA and Prudic, J and Devanand, DP and Nobler, MS and Lisanby, SH and Peyser, S and Fitzsimons, L and Moody, BJ and Clark, J. (2000) A prospective, randomized, double-blind comparison of bilateral and right unilateral electroconvulsive therapy at different stimulus intensities Arch Gen Psychiatry, 57, pp. 425-434.
35. Sartorius, N. (1983) The ICD-10 and depression Acta Psychiatr Scand Suppl, 310, pp. 103-105.
36. Suppes, T and Webb, A and Carmody, T and Gordon, E and Gutierrez-Esteinou, R and Hudson, JI and Pope, HG, Jr. (1996) Is postictal electrical silence a predictor of response to electroconvulsive therapy? J Affect Disord, 41, pp. 55-58.
37. Swartz, CM and Larson, G. (1986) Generalization of the effects of unilateral and bilateral ECT Am J Psychiatry, 143, pp. 1040-1041.
38. Swartz, CM and Abrams, R and Rasmussen, K and Pavel, J and Zorumski, CF and Srinivasaraghavan, J. (1994) Computer automated versus visually determined electroencephalographic and electromyographic seizure duration Convuls Ther, 10, pp. 165-170.
39. Thase, ME and Friedman, ES and Howland, RH. (2000) Venlafaxine and treatment-resistant depression Depress Anxiety, 12(Suppl 1), pp. 55-62.
40. Weiner, RD and Weaver, LA, Jr and Sackeim, HA. (1988) Reporting of Technical Parameters in ECT Publications: Recommendations for Authors Convuls Ther, 4, pp. 88-91.
41. Weiner, RD and Coffey, CE and Krystal, AD. (1991) The monitoring and management of electrically induced seizures Psychiatr Clin North Am, 14, pp. 845-869.
42. World Health Organization. 1992. The ICD-10 Classification of Mental and Behavioural Disorders: Clinical Descriptions and Diagnostic Guidelines). Geneva: World Health Organization.